Kobayashi Pharmaceutical Co Ltd
Kobayashi Pharmaceutical's Climate Target Data Preview
As of 2022, Kobayashi Pharmaceutical has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Kobayashi Pharmaceutical ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Kobayashi Pharmaceutical's Greenhouse Gas Emissions Pathways
As of 2022, Kobayashi Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.
Does Kobayashi Pharmaceutical have a target to reduce the emissions from its operations?
As of 2022, Kobayashi Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Kobayashi Pharmaceutical's most ambitious operational target is to reduce these emissions by 51% by 2030, compared to a baseline of 29,671 Metric Tonnes of CO2 equivalent (mtCO2e) in 2018.
As of 2021, Kobayashi Pharmaceutical is ahead of schedule on its operational emissions reduction target, having achieved 36.49% of the planned reduction.